Simon, Sylvain <br/><br/>
Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy.  [electronic resource] 

 -  Cancer research  12 2017 
 - 7083-7093 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-17-1856  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibody Affinity<br/>Antibody Formation<br/>Antigens, Neoplasm--immunology<br/>Cells, Cultured<br/>Clone Cells<br/>Humans<br/>Immunotherapy--methods<br/>MART-1 Antigen--immunology<br/>Melanoma--immunology<br/>Programmed Cell Death 1 Receptor--immunology<br/>Substrate Specificity<br/>Treatment Outcome